BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15786853)

  • 41. Syncope and presyncope associated with probable adverse drug reactions.
    Hanlon JT; Linzer M; MacMillan JP; Lewis IK; Felder AA
    Arch Intern Med; 1990 Nov; 150(11):2309-12. PubMed ID: 2241439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An evaluation of the adequacy of outpatient monitoring of thyroid replacement therapy.
    Stelfox HT; Ahmed SB; Fiskio J; Bates DW
    J Eval Clin Pract; 2004 Nov; 10(4):525-30. PubMed ID: 15482415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. National study of prescription poisoning with psychoactive and nonpsychoactive medications in Medicare/Medicaid dual enrollees age 65 or over.
    Blackwell SA; Baugh DK; Ciborowski GM; Montgomery MA
    J Psychoactive Drugs; 2011; 43(3):229-37. PubMed ID: 22111406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults.
    Chrischilles EA; VanGilder R; Wright K; Kelly M; Wallace RB
    J Am Geriatr Soc; 2009 Jun; 57(6):1000-6. PubMed ID: 19507293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors of self-reported adverse drug events among Medicare enrollees before and after Medicare Part D.
    Shiyanbola OO; Farris KB; Urmie JM; Doucette WR
    Pharm Pract (Granada); 2009 Oct; 7(4):218-27. PubMed ID: 25136397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for adverse drug events in older adults: the impact of interventions.
    Lukazewski A; Martin B; Sokhal D; Hornemann K; Schwartzwald A
    Consult Pharm; 2014 Oct; 29(10):689-97. PubMed ID: 25275390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting adverse drug events using pharmacological network models.
    Cami A; Arnold A; Manzi S; Reis B
    Sci Transl Med; 2011 Dec; 3(114):114ra127. PubMed ID: 22190238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying Adverse Drug Events in Older Community-Dwelling Patients.
    Cahir C; Wallace E; Cummins A; Teljeur C; Byrne C; Bennett K; Fahey T
    Ann Fam Med; 2019 Mar; 17(2):133-140. PubMed ID: 30858256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Factors Associated with Adverse Drug Events in South Korea Using a Population-Based Database.
    Choi E; Kim S; Suh HS
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of sequential pattern mining to predict next prescribed medications.
    Wright AP; Wright AT; McCoy AB; Sittig DF
    J Biomed Inform; 2015 Feb; 53():73-80. PubMed ID: 25236952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drugs causing adverse events in patients aged 45 or older: a randomised survey of Australian general practice patients.
    Miller GC; Valenti L; Britt H; Bayram C
    BMJ Open; 2013 Oct; 3(10):e003701. PubMed ID: 24114371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of anticonvulsant use and adverse drug events in older adults.
    Moura LMVR; Smith JR; Yan Z; Blacker D; Schwamm LH; Newhouse JP; Hernandez-Diaz S; Hsu J
    Pharmacoepidemiol Drug Saf; 2021 Jan; 30(1):28-36. PubMed ID: 33009718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring the prevalence and characteristics of adverse drug events among older adults in South Korea using a national health insurance database.
    Choi E; Kim S; Suh HS
    Front Pharmacol; 2022; 13():1047387. PubMed ID: 36532737
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessing and predicting drug-induced anticholinergic risks: an integrated computational approach.
    Xu D; Anderson HD; Tao A; Hannah KL; Linnebur SA; Valuck RJ; Culbertson VL
    Ther Adv Drug Saf; 2017 Nov; 8(11):361-370. PubMed ID: 29090085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patients should know procedures to be followed when taking medications.
    Finn A
    Mod Nurs Home; 1969; 23(6):57. PubMed ID: 5196412
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacist Clinical Interventions and Discharge Counseling in Medical Rehabilitation Wards in a Local Hospital: A Prospective Trial.
    Ip RNS; Tenney JW; Chu ACK; Chu PLM; Young GWM
    Geriatrics (Basel); 2018 Aug; 3(3):. PubMed ID: 31011090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regional differences in prescribing quality among elder veterans and the impact of rural residence.
    Lund BC; Charlton ME; Steinman MA; Kaboli PJ
    J Rural Health; 2013; 29(2):172-9. PubMed ID: 23551647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Explicit criteria for potentially inappropriate medications to reduce the risk of adverse drug reactions in elderly people: from Beers to STOPP/START criteria.
    Corsonello A; Onder G; Abbatecola AM; Guffanti EE; Gareri P; Lattanzio F
    Drug Saf; 2012 Jan; 35 Suppl 1():21-8. PubMed ID: 23446783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial.
    Kripalani S; Roumie CL; Dalal AK; Cawthon C; Businger A; Eden SK; Shintani A; Sponsler KC; Harris LJ; Theobald C; Huang RL; Scheurer D; Hunt S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Williams MV; Schnipper JL;
    Ann Intern Med; 2012 Jul; 157(1):1-10. PubMed ID: 22751755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beers criteria as a proxy for inappropriate prescribing of other medications among older adults.
    Lund BC; Steinman MA; Chrischilles EA; Kaboli PJ
    Ann Pharmacother; 2011 Nov; 45(11):1363-70. PubMed ID: 21972251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.